The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

Recent advances toward the development of Hsp90 C-terminal inhibitors - ScienceDirect

Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances - ScienceDirect

PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

NCT-58 (CAS Number: 2411429-33-7)

Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities - ScienceDirect

New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone

Cells, Free Full-Text

Biomolecules, Free Full-Text

New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone

Soeun Park's research works Korea University, Seoul (KU) and other places

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells